Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel and Topotecan With Filgrastim in Recurrent or Refractory Glioblastoma Multiforme or Anaplastic Astrocytoma
NCT00002814Phase 2Completed
- Sponsor
- Dartmouth Health
- Start
- Aug 1996
- Primary completion
- Apr 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, topotecan in glioblastoma multiforme (GBM), anaplastic astrocytoma (AA), sponsored by Dartmouth Health. Started Aug 1996; status: completed.
02
Drugs
paclitaxeltopotecan
03
Conditions
glioblastoma multiforme (GBM)anaplastic astrocytoma (AA)
Beyond the preview
Go deeper on NCT00002814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002814.